Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Alpha Transaminase Mutant. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109609477B details a novel alpha-transaminase mutant enabling 100% conversion in L-glufosinate-ammonium synthesis, offering significant cost reduction and supply chain reliability for agrochemical manufacturers.